首页 › 非小细胞肺癌 › 得克萨斯州 › The Woodlands
The Woodlands TX 非小细胞肺癌临床试验
15项针对 非小细胞肺癌的研究正在 The Woodlands及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Houston Methodist The Woodlands Hospital, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- The University of Texas MD Anderson Cancer Center - Conroe, Conroe · 距离 11 英里
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
招募中3 期
- Texas Oncology - Gulf Coast, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- Texas Oncology - Gulf Coast, The Woodlands
- The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe · 距离 11 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Texas Oncology - Gulf Coast, The Woodlands
- Kelsey-Seybold Clinic - Springwoods Village Campus, Spring · 距离 7 英里
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Community Clinical Trials, Spring · 距离 7 英里
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Renovatio Clinical, The Woodlands
- Woodlands Radiology, The Woodlands
- The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe · 距离 11 英里
- 以及另外 1 项
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- USO - US Oncology Research Network, The Woodlands
Pan-tumor MRD Study
招募中观察性研究
- Community Clinical Trials, Kingwood · 距离 20 英里
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Kingwood · 距离 20 英里
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
招募中3 期
- Research Site, Kingwood · 距离 20 英里
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- USOR - Texas Oncology - The Woodlands, The Woodlands
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
招募中3 期
- Lumi Research, Kingwood · 距离 20 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Renovatio Clinical, The Woodlands
- Community Clinical Trials, Kingwood · 距离 20 英里
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
招募中2 期
- MD Anderson The Woodlands, Conroe · 距离 11 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
The Woodlands的其他研究
- 肥胖症12 项研究
- 超重10 项研究
- 乳腺癌10 项研究
- 黄斑变性9 项研究
- 心血管疾病9 项研究
- 转移性癌症9 项研究
- 2型糖尿病7 项研究
- 心力衰竭7 项研究
- 肺癌7 项研究
- 动脉粥样硬化6 项研究
- 地图样萎缩6 项研究
- 前列腺癌6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。